• FirefoxInstall the new Firefox »
  •  Dow Down 1.54% Nasdaq Down 1.11%

    BioCryst Pharmaceuticals, Inc. (BCRX)

    -NasdaqGS
    10.05 Down 0.18(1.81%) 4:00PM EST
    Add to Portfolio
    Prev Close:10.23
    Open:10.17
    Bid:9.97 x 300
    Ask:10.39 x 200
    1y Target Est:17.38
    Beta:4.08
    Next Earnings Date: 7-May-15BCRX Earnings announcement
    Day's Range:9.97 - 10.26
    52wk Range:7.29 - 14.62
    Volume:692,503
    Avg Vol (3m):856,283
    Market Cap:726.45M
    P/E (ttm):N/A
    EPS (ttm):-0.68
    Div & Yield:N/A (N/A)
    Quotes delayed, except where indicated otherwise. Currency in USD.

    Comparison

    Symbol% ChgMkt Cap
    BCRXDown 1.81%726.45M
    GSKDown 1.83%112.41B
    RHHBYUp 0.47%N/A

    Key Statistics

    Forward P/E (1 yr):N/A
    P/S (ttm):54.37
    Ex-Dividend Date:N/A

    Analysts

    Annual EPS Est (Dec-15) :-1.07
    Quarterly EPS Est (Mar-15) :-0.25
    Mean Recommendation*:2.2
    PEG Ratio (5 yr expected):0.65

    * (Strong Buy) 1.0 - 5.0 (Sell)

    Analyst Opinion | Estimates

    Business Summary

    BioCryst Pharmaceuticals, Inc., a biotechnology company, designs, optimizes, and develops small molecule pharmaceuticals that block key enzymes involved in the pathogenesis of diseases. View More
    Your browser doesn't support canvas
    SETTINGS
    Scrolling
    Speed
    Display
    Price
    Submit Feedback